Serological evaluation of a simplified immunization schedule using quadruple DPT-polio vaccine in Burkina Faso

H C Rümke1, M Schlumberger, B Floury

  • 1RIVM: National Institute of Public Health and Environmental Protection, Bilthoven, The Netherlands.

Vaccine
|January 1, 1993
PubMed

Insights

A two-dose DPT-polio vaccine regimen effectively induces protective antibodies against diphtheria, tetanus, and poliovirus in children. Antibody persistence is good for tetanus and poliovirus, though diphtheria antibodies may wane, indicating strong priming.

Area of Science:

  • Immunology
  • Vaccinology
  • Pediatrics

Background:

  • The Expanded Programme on Immunization (EPI) in Burkina Faso uses a two-dose DPT-polio vaccine schedule.
  • Investigating vaccine immunogenicity is crucial for public health strategies.

Purpose of the Study:

  • To assess the immunogenicity of a two-dose quadruple DPT-polio vaccine regimen in children under 5.
  • To evaluate antibody persistence and the impact of wild poliovirus circulation.

Main Methods:

  • Cross-sectional serological survey of 355 children (179 vaccinated, 176 unvaccinated).
  • Measurement of antibodies against diphtheria toxin, tetanus toxin, and poliovirus types 1, 2, and 3.

Main Results:

  • Over 90% of vaccinated children achieved protective antibody levels for diphtheria, tetanus, and poliovirus after two doses.
  • Antibody persistence for tetanus and poliovirus exceeded 90% at over 2 years post-vaccination.
  • 98% of vaccinated children showed evidence of diphtheria toxin priming, despite antibody decline in some.

Conclusions:

  • A two-dose DPT-polio vaccine strategy is applicable, particularly for poliovirus and tetanus components.
  • A third dose is recommended for adequate pertussis immunity.
  • Wild poliovirus circulation was indicated by antibodies in unvaccinated children, suggesting low vaccination coverage impacted eradication efforts.